News
-
-
-
-
-
-
-
-
PRESS RELEASE
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
Heidelberg Pharma granted orphan drug designation by FDA for its ATAC candidate HDP-101, targeting multiple myeloma. The designation provides significant benefits for the development and potential marketing of the drug -
-
PRESS RELEASE
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
Heidelberg Pharma AG announces financial figures and successful business performance in 2023, including efficacy data from HDP-101 clinical trial. New Management Board team and expansion of ADC technology platform
![Accesswire](/assets/images/accesswire-inline.png)
-
Southern Energy Corp. Announces Amendments to Outstanding Convertible Debentures
-
TEAM JOOPITER Collection Will Be Officially Launched on June 18
-
The Juneteenth Foundation is Back With Its 4th Annual Juneteenth Honors Festival in Washington, DC, Continuing the Movement to Make Juneteenth a Staple Holiday Across America
-
BRIXY’s New Shampoo Bars Lather on the Benefits: Hydrating and Strengthening Formulations That Help Preserve Hair and the Planet
-
Ascendant Resources Announces Results of Annual General Meeting of Shareholders
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: IVU Traffic Technologies AG decides to buy back shares
-
beaconsmind Group expands in education sector with innovative media technologies
-
Cantourage Group SE records highest monthly revenue in company history in May 2024
-
Cairn Homes Plc: Transaction in Own Shares
-
Wacker Neuson Group opens new distribution center in Mülheim-Kärlich
![Les Echos](/assets/images/les-echos.png)
-
Europorte and Kerlink revolutionize freight by launching Track Value, the first logistics application using Kinéis IoT space connectivity
-
AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2024
-
Declaration of voting rights at the end of May 2024
-
The Board of Directors renews Iris Knobloch as Chair of the Board of Directors
-
CDA - Acquisition of 86,5% of Urban Group